ArticleFrontiers in medicine2025
Correlation between hemoglobin-to-albumin ratio and complications after radical gastrectomy in gastric cancer patients.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients who undergo radical gastrectomy for gastric cancer often experience multiple complications that affect the recovery process and reduce quality of life. The hemoglobin-to-albumin ratio (HAR) reflects nutritional status and is widely used to assess various diseases. However, its association with complications after radical gastrectomy in gastric cancer patients has not been fully explored. Methods: This study retrospectively analyzed clinical and pathological data from 352 gastric cancer patients who underwent radical gastrectomy at the Second Hospital of Lanzhou University between January 2023 and December 2024. The severity of postoperative complications was graded using the Clavien-Dindo classification system, resulting in two groups: non-complication group ( Results: Multivariate logistic regression analysis showed that for every 1-unit increase in HAR, the risk of Clavien-Dindo ≥II grade complications decreased by 62.0% (95% CI: 0.188-0.749; Conclusion: This study indicates that higher HAR is significantly and negatively correlated with the risk of complications. Higher levels of HAR effectively prevent Clavien-Dindo ≥ II-grade complications. Consequently, HAR can serve as a clinically useful indicator for predicting complications following radical gastrectomy for gastric cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.